Increased leptin and tumour necrosis factor α per unit fat mass in hypopituitary women without growth hormone treatment

被引:8
作者
Bülow, B [1 ]
Ahrén, B [1 ]
Erfurth, EM [1 ]
机构
[1] Lund Univ, Dept Med, Lund, Sweden
关键词
D O I
10.1530/eje.0.1450737
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The adipocyte products, leptin and tumour necrosis factor (TNF)alpha are associated with atherosclerotic diseases and may be factors contributing to the enhanced cardiovascular risk in hypopituitary patients with growth hormone (GH) deficiency. Objective: To investigate whether leptin and TNF alpha are increased in a group of hypopituitary women previously found to have increased cardiovascular morbidity, and to compare them with matched individuals of the same sex and age and with similar body composition. Design and Patients: Thirty-three GH-deficient women with a median age of 64 years (range 39-77 years) were investigated cross-sectionally. The patients were compared with 33 controls matched for sex, age, smoking habits, educational level and residence. Methods: Body composition was measured by bioimpedance analysis. Fasting concentrations of leptin, TNF alpha and insulin were analysed in patients and controls. Results: There was no significant difference in body mass index or fat mass between patients and controls (both P greater than or equal to 0.4). Serum leptin did not differ significantly between patients and controls. However, when serum leptin concentrations were expressed per kilogram fat mass, the patients had significantly greater concentrations (P = 0.01). Serum TNF alpha and TNF alpha per kilogram fat mass were also significantly greater in the patients (both P = 0.001). In contrast, serum insulin did not differ significantly between patients and controls. In the patients, serum leptin concentrations correlated positively with kilogram fat mass (r = 0.54, P = 0.002). Leptin concentration per kilogram fat mass was positively correlated with insulin (r = 0.40. P = 0.03). Conclusions: In contrast to serum concentrations of TNF alpha. serum leptin did not differ from that in controls, implying that leptin is not a major contributor to the previously found increase in cardiovascular morbidity in the hypopituitary women investigated. However, the patients had increased leptin concentrations per unit fat mass, indicating an altered adipocyte secretory function in this group.
引用
收藏
页码:737 / 742
页数:6
相关论文
共 43 条
[1]   Adipose tissue as an endocrine organ [J].
Ahima, RS ;
Flier, JS .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) :327-332
[2]   Leptin -: A regulator of islet function?: Its plasma levels correlate with glucagon and insulin secretion in healthy women [J].
Ahrén, B ;
Larsson, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (12) :1477-1481
[3]   Elevated leptin concentrations in growth hormone-deficient hypopituitary adults [J].
AlShoumer, KAS ;
Anyaoku, V ;
Richmond, W ;
Johnston, DG .
CLINICAL ENDOCRINOLOGY, 1997, 47 (02) :153-159
[4]   COMPARISON OF ACID ETHANOL EXTRACTION AND ACID GEL-FILTRATION PRIOR TO IGF-I AND IGF-II RADIOIMMUNOASSAYS - IMPROVEMENT OF DETERMINATIONS IN ACID ETHANOL EXTRACTS BY THE USE OF TRUNCATED IGF-I AS RADIOLIGAND [J].
BANG, P ;
ERIKSSON, U ;
SARA, V ;
WIVALL, IL ;
HALL, K .
ACTA ENDOCRINOLOGICA, 1991, 124 (06) :620-629
[5]   ASSESSMENT OF GH STATUS IN ADULTS WITH GH DEFICIENCY USING SERUM GROWTH-HORMONE, SERUM INSULIN-LIKE GROWTH-FACTOR-I AND URINARY GROWTH-HORMONE EXCRETION [J].
BATES, AS ;
EVANS, AJ ;
JONES, P ;
CLAYTON, RN .
CLINICAL ENDOCRINOLOGY, 1995, 42 (04) :425-430
[6]   Bioelectrical impedance analysis during acute changes of extracellular osmolality in man [J].
Berneis, K ;
Keller, U .
CLINICAL NUTRITION, 2000, 19 (05) :361-366
[7]  
Bianda TL, 1997, DIABETOLOGIA, V40, P363
[8]   Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I [J].
BoniSchnetzler, M ;
GosteliPeter, MA ;
Moritz, W ;
Froesch, ER ;
Zapf, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (01) :296-301
[9]   Modulating effect of human growth hormone on tumour necrosis factor-α and interleukin-1β [J].
Bozzola, M ;
De Amici, M ;
Zecca, M ;
Schimpff, RM ;
Rapaport, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (06) :640-643
[10]   Increased cerebrovascular mortality in patients with hypopituitarism [J].
Bulow, B ;
Hagmar, L ;
Mikoczy, Z ;
Nordstrom, CH ;
Erfurth, EM .
CLINICAL ENDOCRINOLOGY, 1997, 46 (01) :75-81